TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Orion Pharma A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
253,050
|
214,175
|
212,530 |
Earnings before taxes |
10,981
|
9,823
|
6,095 |
Total assets |
89,648
|
83,090
|
86,680 |
Current assets |
89,446
|
82,958
|
86,513 |
Current liabilities |
37,963
|
32,637
|
38,756 |
Equity capital |
51,685
|
50,453
|
47,924 |
- share capital |
3,000
![]() |
3,000
![]() |
3,000 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.7%
|
60.7%
|
55.3% |
Turnover per employee |
7,230
|
6,119
|
6,072 |
Profit as a percentage of turnover |
4.3%
|
4.6%
|
2.9% |
Return on assets (ROA) | |||
Current ratio |
235.6%
|
254.2%
|
223.2% |
Return on equity (ROE) |
21.2%
|
19.5%
|
12.7% |
Change turnover |
38,875
|
1,645
|
-70,337 |
Change turnover % |
18%
|
1%
|
-25% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.